Webinar On-Demand: Shift the Paradigm to Centrifuge-less Immuno-staining of Cells for Superior Viability, Recovery & Data

Now Watching

Automating Cell Therapy Product: Constraints and Product Qualification for Fit-to-Process

When cells matter, it is key to prioritize their care at every stage. Clear resolution and retention of rare cell populations proves to be an issue in cell therapy processing utilizing traditional centrifugation methods. Automated, reproducible sample prep that does not rely on manual handling is the missing piece to saving precious samples, time, and money.

The major key cost drivers of the autologous CAR T-cell therapy are generally QC analytics and biocharacterization of viral vector and supporting starting biomaterials, all of which could be outsourced costs or could be developed and managed in-house.

This Fierce Biotech Webinar features Nelson Carramanzana from Kite Pharma, where he provides insight into CoGs, lifecycle, and supply chain costs for these expensive cell therapies.

Subscribe to our newsletter

Get updates about upcoming webinar technical application information and product announcements when you subscribe to the Curiox newsletter.